kidney stones

You have accessRestricted Access
Temporal Trends of Dietary Risk Factors after a Diagnosis of Kidney Stones
Pietro Manuel Ferraro, Tamara Da Silva Cunha, Eric N. Taylor and Gary C. Curhan

CJASN January 2022, 17 (1) 83-89; DOI: https://doi.org/10.2215/CJN.09200721

Add to Selected Citations
Open Access
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1
Yaacov Frishberg, Georges Deschênes, Jaap W. Groothoff, Sally-Anne Hulton, Daniella Magen, Jérôme Harambat, William G. van’t Hoff, Ulrike Lorch, Dawn S. Milliner, John C. Lieske, Patrick Haslett, Pushkal P. Garg, Akshay K. Vaishnaw, Sandeep Talamudupula, Jiandong Lu, Bahru A. Habtemariam, David V. Erbe, Tracy L. McGregor, Pierre Cochat and on behalf of the study collaborators

CJASN July 2021, 16 (7) 1025-1036; DOI: https://doi.org/10.2215/CJN.14730920

Add to Selected Citations
You have accessRestricted Access
Racial Differences in Risk Factors for Kidney Stone Formation
Anna L. Zisman, Fredric L. Coe, Andrew J. Cohen, Christopher B. Riedinger and Elaine M. Worcester

CJASN August 2020, 15 (8) 1166-1173; DOI: https://doi.org/10.2215/CJN.12671019

Add to Selected Citations
Open Access
End Points for Clinical Trials in Primary Hyperoxaluria
Dawn S. Milliner, Tracy L. McGregor, Aliza Thompson, Bastian Dehmel, John Knight, Ralf Rosskamp, Melanie Blank, Sixun Yang, Sonia Fargue, Gill Rumsby, Jaap Groothoff, Meaghan Allain, Melissa West, Kim Hollander, W. Todd Lowther and John C. Lieske

CJASN July 2020, 15 (7) 1056-1065; DOI: https://doi.org/10.2215/CJN.13821119

Add to Selected Citations
You have accessRestricted Access
Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan
Matteo Bargagli, Nasser A. Dhayat, Manuel Anderegg, Mariam Semmo, Uyen Huynh-Do, Bruno Vogt, Pietro Manuel Ferraro and Daniel G. Fuster

CJASN July 2020, 15 (7) 1007-1014; DOI: https://doi.org/10.2215/CJN.13861119

Add to Selected Citations
Open Access
Primary Hyperoxaluria
Jennifer E. Lawrence and Debra J. Wattenberg

CJASN July 2020, 15 (7) 909-911; DOI: https://doi.org/10.2215/CJN.13831119

Add to Selected Citations
You have accessRestricted Access
ADPKD, Tolvaptan, and Nephrolithiasis Risk
Ewout J. Hoorn and Robert Zietse

CJASN July 2020, 15 (7) 923-925; DOI: https://doi.org/10.2215/CJN.07610520

Add to Selected Citations
You have accessRestricted Access
Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease–Related Medications in Veterans
Shen Song, I-Chun Thomas, Calyani Ganesan, Ericka M. Sohlberg, Glenn M. Chertow, Joseph C. Liao, Simon Conti, Christopher S. Elliott, Alan C. Pao and John T. Leppert

CJASN December 2019, 14 (12) 1773-1780; DOI: https://doi.org/10.2215/CJN.03580319

Add to Selected Citations
You have accessRestricted Access
Recurrent Calcium Kidney Stones
Lada Beara-Lasic and David S. Goldfarb

CJASN September 2019, 14 (9) 1388-1390; DOI: https://doi.org/10.2215/CJN.02550319

Add to Selected Citations
You have accessRestricted Access
Net Acid Excretion and Urinary Organic Anions in Idiopathic Uric Acid Nephrolithiasis
I. Alexandru Bobulescu, Sun K. Park, L.H. Richie Xu, Francisco Blanco, John Poindexter, Beverley Adams-Huet, Taylor L. Davidson, Khashayar Sakhaee, Naim M. Maalouf and Orson W. Moe

CJASN March 2019, 14 (3) 411-420; DOI: https://doi.org/10.2215/CJN.10420818

Add to Selected Citations

Main menu

User menu

Search

kidney stones

Pages

Articles

Information for Authors

About

Journal Information

More Information